211 related articles for article (PubMed ID: 1552287)
1. Skin graft rejection by beta 2-microglobulin-deficient mice.
Zijlstra M; Auchincloss H; Loring JM; Chase CM; Russell PS; Jaenisch R
J Exp Med; 1992 Apr; 175(4):885-93. PubMed ID: 1552287
[TBL] [Abstract][Full Text] [Related]
2. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
4. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
Apasov SG; Sitkovsky MV
J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
[TBL] [Abstract][Full Text] [Related]
5. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
6. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
Apasov S; Sitkovsky M
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
[TBL] [Abstract][Full Text] [Related]
7. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
Rosenberg AS; Munitz TI; Maniero TG; Singer A
J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
[TBL] [Abstract][Full Text] [Related]
8. Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts.
Li X; Faustman D
Transplantation; 1993 Apr; 55(4):940-6. PubMed ID: 8475570
[TBL] [Abstract][Full Text] [Related]
9. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
10. In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.
Rees MA; Rosenberg AS; Munitz TI; Singer A
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2765-9. PubMed ID: 2138785
[TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.
Zijlstra M; Bix M; Simister NE; Loring JM; Raulet DH; Jaenisch R
Nature; 1990 Apr; 344(6268):742-6. PubMed ID: 2139497
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
[TBL] [Abstract][Full Text] [Related]
13. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.
Bix M; Liao NS; Zijlstra M; Loring J; Jaenisch R; Raulet D
Nature; 1991 Jan; 349(6307):329-31. PubMed ID: 1987491
[TBL] [Abstract][Full Text] [Related]
14. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
15. MHC class I-deficient mice.
Raulet DH
Adv Immunol; 1994; 55():381-421. PubMed ID: 8304235
[TBL] [Abstract][Full Text] [Related]
16. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.
Udaka K; Marusić-Galesić S; Walden P
J Immunol; 1994 Sep; 153(6):2843-50. PubMed ID: 7915743
[TBL] [Abstract][Full Text] [Related]
17. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
[TBL] [Abstract][Full Text] [Related]
18. Evidence for differentiation of NK1+ cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts.
Dennert G; Knobloch C; Sugawara S; Yankelevich B
Immunogenetics; 1990; 31(3):161-8. PubMed ID: 2108082
[TBL] [Abstract][Full Text] [Related]
19. Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
Johnson LL; Hines DL
Immunology; 1990 Jan; 69(1):85-90. PubMed ID: 2312158
[TBL] [Abstract][Full Text] [Related]
20. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity.
Liao NS; Bix M; Zijlstra M; Jaenisch R; Raulet D
Science; 1991 Jul; 253(5016):199-202. PubMed ID: 1853205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
